Clinical psychologist Talia Zaider offers guidance to those whose friend or loved one is facing terminal illness.
Memorial Sloan Kettering physician-scientists have prevented a dangerous complication of stem cell transplantation using immune cells donated from a third party.
Our conversation about active surveillance of prostate cancer continues. Let’s take a closer look at our protocols for selecting and monitoring patients.
Thanks to recent treatment advances, many people diagnosed with liver cancer today can expect to survive the disease. But experience counts.
CyberKnife is a brand name for one of several available devices that deliver intense doses of radiation with very high accuracy.
Cycle for Survival, Memorial Sloan Kettering’s nationwide indoor team cycling event, helps support research into rare cancers. Three researchers discuss how these funds benefit their research.
The new guidelines take aim at resolving questions over whether surgery to remove additional normal tissue is needed in breast cancer patients who’ve already had a lumpectomy.
Chaplaincy provides spiritual care that addresses questions of identity, meaning, value, and worth that may or may not be expressed in religious terms.
Investigators have found a possible molecular explanation for why obese people with kidney cancer tend to fare better despite having a higher rate of diagnosis.
A recent web chat features medical oncologist Steven M. Horwitz discussing advances in the diagnosis and treatment of lymphoma.